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Isolation of YAC Clones From the Pericentromeric Region of
Chromosome 10 and Development of New Genetic Markers Linked
to the Multiple Endocrine Neoplasia Type 2A Gene
Terry C. Lairmore,* James R. Howe,* Shenshen Dou,^ Rosalie Veile,^ Jennifer A.
Korte-Sarfaty,^ Samuel A. Wells, Jr,* and Helen Donis-Keller^
Genetic linkage mapping and contig assembly using yeast artificial chromosome (YAC) technology
form the basis of our strategy to clone and define the genomic structure ofthe pericentromeric region
of chromosome 10 containing the multiple endocrine neoplasia type 2A gene. Thus far YAC walks
have been initiated from five chromosome 10 pericentromeric loci including RBP3, D10S94, RET.
DlOZl, and FNRB. Long range pulsed-field gel electrophoresis maps are constructed from the YACs
isolated to define clone overlaps and to identify putative CpG islands. Bidirectional YAC walks are
continued by rescreening the YAC library with sequence-tagged site assays developed from endclones. Several new restriction fragment length polymorphisms and simple sequence repeat polymorphism markers have been identified from the YAC clones. In particular, two highly informative
(CA)^ dinucleotide repeat markers, sTCL-1 from proximal chromosome lOp (16 alleles, PIC = 0.68)
and sJRH-1 from the RBP3 locus (18 alleles. PIC = 0.88), provide useful reagents for a polymerase
chain reaction-based predictive genetic test that can be performed rapidly from small amounts of
DNA. (Henry Ford Hosp Med J1992 ;40:210-14)

E

fforts to identify the genetic defect(s) responsible for the
multiple endocrine neoplasia type 2 (MEN 2) syndromes
based on their known chromosomal map position rely on the interplay between linkage analysis and physical mapping. This
"positional cloning" approach begins with genetic linkage analysis in large disease pedigrees to identify the smallest interval
containing the disease locus defined by fianking markers. Subsequendy, physical mapping strategies such as hybrid panel
mapping and contig construction using large insert cloning systems (e.g., cosmids and yeast artificial chromosomes [YACs])
may be employed to further characterize the region of interest.
In addition, detectable germline or somatic chromosomal rearrangements may be sought which could potentially provide important clues to the location of the defect(s).
Genetic linkage studies from several laboratories have assigned the multiple endocrine neoplasia type 2A disea.se gene
(MEN2A) to the interval between the fianking markers RBP3 in
1 Oqi 1.2 and D10S34 in lOpll.2 (1-7). Linkage o f t h e disease
locus to chromosome 10 pericentromeric markers has also been
shown in families segregating the defect(s) responsible for the
MEN 2 syndrome with the mucosal neuroma phenotype (MEN
2B) (8,9) and familial medullary thyroid carcinoma (9-11). Currently, at least five markers have been described which map
within this interval and show no recombination with respect to
the MEN2A locus, including D10S97 (12), D10S102 (7,13),
D10S94 (14), the ret proto-oncogene (7,15), and DlOZl (5,6,
16). Further progress using meiotic mapping is limited by the reduced recombination rate, especially in males, which has been
reported (5,17) in this region and the availability of critical recombinants within the interval of interest.
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We have employed YAC walking and physical mapping to
further characterize the pericentromeric region of chromosome
10 containing MEN2A. The requirements for success using this
approach are the availability of multiple markers within the region of interest, which can be used as entry points for bidirectional chromosomal walking, and efficient isolation of terminal
sequences from YAC clones for library rescreening. In this report we summarize the results of the YAC mapping effort, including the strategies used for identification of YAC endclones, detection of chimeric YAC clones, and screening for
highly informative markers within the cloned DNA.

Methods
Development of sequence-tagged sites
Oligonucleotide primers were chosen from published or derived sequences from each entry point locus, and a specific
polymerase chain reaction (PCR) assay defining the sequencetagged site (STS) (18) was developed. The primer choice computer program named PRIMER (provided by M . Daly, S. Lincoln, and E. Landers, Whitehead Institute) was used to choose
optimal primer pairs based on calculated melting temperatures
and low intra- and inter-primer sequence homology. Genetic seSubmitted for publication: November 15.1991,
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quence data bases (e.g., GenBank) were searched with the
primer sequences to test for homology to known human sequences or repetitive elements. Thermal cycling reaction conditions were optimized for each PCR assay. Then, the specificity
of each primer pair was tested by PCR amplification from a
panel of somatic cell hybrid DNAs (obtained primarily from the
NIGMS mutant cell repository, Camden, NJ) and was shown to
amplify a product of expected size only from DNA templates
containing chromosome 10.
The PCR amplification was performed from 50 ng of total
genomic human DNA in a reaction volume of 5 jxL including a
final concentration of 200 \xM for each dNTP, I p,M for each
primer, 50 mM KCl, 10 mM Tris-HCl pH 8.4, 1.5 mM MgCL
and 0.5 units of AmpliTaq (Perkin-Elmer Cetus, Norwalk, CT).
The reaction was carried out for 30 cycles of 94 °C for 1 minute,
50 to 65 °C for 2 minutes, and 72 °C for 2 minutes in a PerkinElmer Thermal Cycler.
PCR-based YAC library screening
The human genomic YAC library at the Center for Genetics
in Medicine (Washington University, St. Louis, MO) was
screened using a previously described strategy based on PCR
amplification from DNA pools (19). First, PCR amplification is
performed from 36 DNA pools representing the entire library.
Each pool consists of DNA from the 1,920 YAC clones which
are contained on five single membranes (384 clones each). In a
second round of screening, PCR amplification is performed
from each positive pool along with the pooled DNAs from the
clones from each of five single membranes. In the final step of
library screening, the radiolabeled PCR product is hybridized to
the positive single membranes to identify the desired YAC
clones.
Pulsed-field restriction mapping of YAC clones
High molecular weight genomic yeastA'AC DNA was prepared (20) and digested with rare-cutting restriction enzymes
according to conditions specified by the manufacturer. The
DNA fragments were separated in a 1 % agarose gel in 0.5X TBE
by pulsed-field gel electrophoresis, depurinated in 0.1 N HCl
and then transferred to nylon filters (Zeta-bind, AMF/Cuno,
Meriden, CT) in 1.5 M NaCI and 0.25 N NaOH. Left and right
terminal fragments were identified by hybridization with probes
specific for the right and left vector arms of pYAC4 (21). In addition, double digest and partial digestion experiments foUowed
by hybridization with radiolabeled YAC-derived DNA probes
were used to order the intemal fragments.
Construction of subclone libraries and screening for new
restriction fragment length polymorphism probes and
dinucleotide repeats
Subclone libraries were prepared by partial digestion of yeast/
YAC DNA with Mbol or Sau3A to generate fragments 13 to 22
kb in size, followed by ligation into the BamHI site of
>iEMBL3A or XDASH II (Stratagene, La Jolla, CA). Libraries
of approximately five yeast genome-equivalents in size were
plated and nylon filter plaque lifts were prepared. Human sequence-containing clones were identified by hybridization with
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Table 1
YAC Clones Identified by Screening of a Human
Genomic Library with Chromosome 10
Pericentromeric STS Markers
Clone

Locus

yIR-1*
yIR-2
yIR-3
yIR-4
yZ-I

RBP3
RBP3
RBP3
RBP3
DlOZl
DlOZl
DlOZl
DlOZl
DlOZl
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB
FNRB

yz-2t
yZ-3
yZ-4
yZ-5
yFN-I
yFN-2
yFN-3
yFN-4
yFN-5
yFN-6
yFN-7
yFN-8t
yFN-9
yFNlO*
yFN-I I

Size (kb)
200
7.50
425
240
13.i

n.s
60
80.430
115
Unknown
170
185
100
300
195,375
260
300
280
300

*Clones known to be derived entirely from chromosome 10.
fClones knov.'n to be chimeric.

radiolabeled total human DNA (22). Human sequence-containing clones were tested for the detection of restriction fragment
length polymorphisms (RFLPs) by Southem hybridization to
screening panels containing genomic DNAs from six unrelated
individuals restricted with BamHI, BglU, EcoRI, Hindi,
Hindlll, Mspl, Pstl, TaqI, EcoRV, Hinfl, PvuII, and Rsal (23).
Lambda subclones containing (CA)„ repeat elements (24) were
identified by hybridization with poly(dC-dA)j, x (dG-dT)^,
(Pharmacia, Piscataway, NJ) labeled by nick-translation. The
(CA)j,-positive lambda clones were then further digested to fragments 200 to 500 bp in size and subcloned into Ml3 or
pBluescript (Stratagene, La Jolla, CA) for sequencing and development of primers for PCR amplification of the CA repeat elements.

Results
Identification of YAC clones from chromosome 10
pericentromeric loci
YAC screening has been initiated from five chromosome 10
pericentromeric markers tightly linked to MEN2A, including
RBP3, D10S94, RET, DlOZl, and FNRB. Currently, a total of
four clones have been identified for the RBP3 locus, five clones
for the chromosome lO-specific alphoid repeat marker DlOZl,
11 clones for the FNRB locus, and six clones for the D10S94 locus (Table 1) (YACs isolated from the D10S94 and RET loci are
in the preliminary stages of characterization and will not be discussed in detail).
The PCR assay used to screen for YAC clones from the RBP3
locus was developed from the cDNA sequence of the interstitial
retinol-binding protein gene (IRBP) (25). Two of the YAC
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Table 2
New Genetic Markers Detecting RFLPs From the
Pericentromeric Region of Chromosome 10
Locus

Probe

FNRB
FNRB
RBP3
RBP3
RBP3
RBP3

pTCL-10
LTCL-2
JH-1
JH-2
JH-3
JH-4

Enzyme

Alleles

Bglll
Mspl
Bglll
TaqI
Hindlll
TaqI

Heterozygosity

3
2
2
2
2
3

0.55
0.43
0.41
0.48
0.46
0.34

PIC*

Reference

(1.46
0.34
0.32
0.37
0.36
0.28

(28)
(28)
(9,26)
(9)
(9)
(9,26)

Dinucleotide Repeat Polymorphisms
From the Pericentromeric Region of Chromosome 10

ssRP-r

Dinucleotide Repeat

Numberof Alleles

PIC*

sTCL-l
sJRH-l

(CA)„
(CA)„

16
IK

0.68
0.88

Reference
(36)
(36)

*PIC denotes polymorphism informalion content.
tSSRP denotes simple sequence repeat polymoiphism.

clones identified from the RBP3 locus have been characterized
in some detail. The YAC clone yIR-1 is a 200 kb continuous
segment of chromosome 10 containing the IRBP gene (26).
Four new RFLP markers (JH-1, JH-2, JH-3, and JH-4) have
been identified from this clone which greatly increase the informativeness of this locus when haplotyped with the previously
described RFLPs at RBP3 (Table 2). In addition, a highly informative dinucleotide repeat element, sJRH-1 (Table 2), has been
identified from the 750 kb clone yIR-2 and shown to be tightly
linked to the MEN 2A disease locus. The 750 kb clone is known
to contain the smaller 200 kb clone.
Two separate PCR assays were developed from different
parts ofthe 3.6 kb FNRB cDNA sequence (27). The first set of
primers was chosen from the middle ofthe cDNA sequence and
the second set of primers was chosen about 300 bp after the signal sequence but before the cysteine-rich repeat region. A total
of 11 clones were identified by screening of the YAC library
with these two assays (Table 1). An approximately 280 kb YAC,
yFN-10, is derived entirely from chromosome 10 and contains a
putative CpG island identified by the cluster of rare-cutting restriction sites in close proximity to the FNRB gene (Figure)
(28). An additional clone, yFN-8, has been characterized and
found to be a chimeric clone containing a portion of chromosome 10 and a portion of chromosome 4 (28). Two new RFLP
probes (pTCL-10, LTCL-2), as well as a highly informative
dinucleotide repeat polymorphism (sTCL-1), have been identified from the FNRB YAC clones (Table 2) which enhance the
informativeness of this locus for linkage mapping and predictive genetic testing.
Finally, a PCR assay specific for chromosome 10 centromere
alpha satellite sequences was developed and used to screen the
YAC library (29), and five clones were identified (Table 1).
Rapid detection of chimeric YAC clones using IRS-PCR
In order to quickly confirm the chromosomal origin of YAC
clones and to detect probable chimeric clones (derived from two
different chromosomes), we have employed interspersed repeti-
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tive sequence polymerase chain reaction (IRS-PCR) (30-32).
This technique involves the generation of the specific set of
DNA fragments amplified from each YAC clone using primers
directed at interspersed repetitive sequences, such as the Alu517 primer (30) or the PDJ34 primer (33), and hybridization of
the products generated to a "slot blot" containing PCR products
generated with the same primer from a panel of somatic cell hybrid lines.
First, the Alu primer is used to amplify the specific population of fragments or "fingerprint" of Alu-PCR products from
each memberof a panel of somatic cell hybrid lines representing
virtually all 24 human chromosomes. The majority of these hybrids contain only one human chromosome or a few human
chromosomes. The PCR products generated from each hybrid
line are then spotted onto a nylon filter (slot blot). Second, the
Alu primer is used to amplify the specific DNA fragments from
the YAC clone, and the resulting products are then radiolabeled
by the random hexamer priming method (34) and u.sed as a hybridization probe against the slot blot of hybrid line PCR products. This method is very sensitive because of the amplified nature of the products, requiring exposure times on the order of
hours. A strong hybridization signal is usually obtained from
each line containing a chromosome of origin for the YAC clone,
although a faint background signal is sometimes seen for other
lines. In addition to confirming derivation of at least a portion of
the YAC clone from the appropriate chromosome, this method
provides a rapid way to identify probable chimeric clones based
on strong hybridization signals representing two different chromosomes. This initial characterization can be performed rapidly
in a single PCR reaction from yeast mini-prep DNA or potentially even from a cmde lysate of yeast cells.
Strategies used for identification of terminal sequences
from YAC clones
YAC end-clones may be identified by standard subcloning
techniques followed by hybridization with probes specific for
either the right or left vector arm of pYAC4. This strategy is vir-
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tually always successful, but is relatively labor intensive and
therefore is not well-suited to the simultaneous characterization
of multiple clones of interest. Lambda subclone libraries constructed from genomic yeastAA.C DNA are screened with sequences derived from pBR322 which hybridize specifically to
eitherthe left or right vector arm. Primers have been synthesized
for the convenient generation of these probes by PCR amplification from 1 ng or less of pBR322 DNA. The products are radiolabeled during the thermal cycling reactions. The chromosomal
origin of the lambda end-clones may then be determined by hybridization to Southem blots containing DNAs from a somatic
cell hybrid panel, or by genetic linkage analysis if the clone
identifies an RFLP.
A variety of PCR-based strategies for the rapid isolation of
YAC end-clone sequences have been described. Specific amplification of the junction of the vector arm and the terminal portion ofthe human insert using a vector arm-derived primer and a
primer directed to Alu repetitive elernents is termed Alu-vector
PCR (33). This method depends on the presence of an Alu repeat
element in the human insert in the proper orientation and within
adistance which may be amplified by PCR. An additional rapid
method for isolating the terminal (end-clone) sequences from
YAC clones is provided by the recently described "vectorette"
technique (35). This strategy involves digestion of the YAC
clone with relatively frequentiy-cutting restriction enzymes
(chosen not to cleave the vector between the cloning site and the
sequences for available vector arm primers), ligating a specially
designed linker with a noncomplementary central region termed
a "vectorette" onto the population of restriction fragments, and
then specifically amplifying the terminal sequences using a vector-derived and a linker-derived primer. Because the vectorette
has an intemal region of noncomplementarity, only those fragments undergoing an initial round of extension from the vector
arm primer will have the needed sequences present to extend
from the vectorette primer. This fact provides specific amplification of only the end-clone sequences from the complex background. The products generated by Alu-vector PCR or the vectorette method may then be sequenced by standard strategies for
direct sequencing of PCR products (or after cloning into a plasmid vector).
Currently, 20 (91%) of the 22 ends from the 11 YAC clones
which have been most extensively characterized have been isolated using one ormore ofthe above methods. Nine (41%) of the
ends were isolated by lambda subcloning and hybridization with
probes specific for the right or left YAC vector arms. Mapping
information for these clones was obtained either by hybridization to somatic cell hybrid blots or by linkage analysis. Seven
(32%) additional ends identified by lambda subcloning and
plaque hybridization were further subcloned into a plasmid vector for sequencing of 150 to 250 bp of the human insert near the
vector-insert junction. New STS assays are developed from this
sequence information for mapping by PCR amplification from a
panel of somatic cell hybrid DNAs. Finally, specific PCR products from four (18%) of the ends have been identified by either
Alu-vector or alphoid-vector amplification of the vector-insert
junction. Five of the ends were isolated by both subcloning and
PCR-based methods.
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Figure—Rare-cutting restriction map of yFN-10 YAC clone
with the map positions of the RFLP probe LICL-2 and the
FNRB gene indicated (28).

Conclusion
Our group has approached characterization of the pericentromeric region of chromosome 10 containing the MEN 2
gene(s) using combined genetic linkage mapping and physical
mapping strategies. YAC walks have been initiated from five
loci linked to the MEN2A locus, including RBP3, D10S94,
RET, DlOZl, and FNRB. New highly informative markers, including two dinucleotide repeat polymorphisms, have been developed from the YAC clones identified from the RBP3 and
FNRB loci. These markers have increased the informativeness
of the flanking markers and should provide a higher likelihood
of identifying critical recombinants in the disease gene region as
well as a refined genetic map. In addition, the highly informative dinucleotide repeat polymorphisrns may be applied to a
rapid PCR-based predictive genetic test for the MEN 2 syndromes.
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